Horizons Series: Rapid Genotyping for Therapy Selection in Patients with Lung Cancer

Log in for pricing

(No reviews yet) Write a Review
SKU:
311HZN23-001


 Rapid Genotyping for Therapy Selection in Patients with Lung Cancer

This contains the webinar and continuing education credit (CME and CMLE) 

Description:

Therapy selection for patients with early-stage and advanced lung cancer relies on biomarker testing.  In this educational session we will outline a rapid lung cancer program implemented at the MGH Cancer Center.


Learning Objectives:

    • Discuss clinical indications for molecular testing in patients with lung cancer
    • List relevant components of the program
    • Define diagnostic quality of rapid genotyping
    • Access the MGH order set for lung cancer




Speaker:
Jochen K. Lennerz, MD, PhD
Massachusetts General Hospital
Harvard Medical School

Moderator:

Ibiayi Dagogo-Jack, MD
Massachusetts General Hospital
Harvard Medical School



Moderator
:

Adam Fisch, MD, PhD
Massachusetts General Hospital
Harvard Medical School


Duration: 1 Hour
Level of Instruction: Intermediate
Date Recorded: January 24, 2023

Planned and coordinated by the Training and Education Committee

Continuing Education Credit Information

CME credit: 1.0
CMLE credit: 1.0 
Last day to claim credit:  March 20, 2025

Accreditation Statements
AMA PRA Category 1 Credit(s)
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 


Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.